Directory

>

Gregory Gin

avatar

Gregory Gin

Vice President, Investor Relations and Corporate Communications | Abeona Therapeutics

United States

View contact details (it's free)

Gregory Gin

Summary

Gregory Gin is a seasoned professional with over 25 years of experience in investor relations and corporate communications, particularly within the life sciences sector. Currently serving as Vice President at Abeona Therapeutics, he has a proven track record of enhancing shareholder value and driving successful capital market strategies. His expertise spans across various therapeutic areas, including neurology and oncology, and he has led investor relations programs at multiple public companies. Gregory is recognized for his analytical skills and his ability to thrive in fast-paced environments. He has effectively managed communication strategies that have resulted in increased investor engagement and coverage. His strategic insights have supported substantial capital raises and investor targeting efforts, making him a valuable asset to any organization.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Leadership Development

Organisational experience

Corporate Experience

Consulting Experience

Gregory Gin

Work Experience

company logo

Vice President, Investor Relations and Corporate Communications at

Abeona Therapeutics

May 2020 - Present

company logo

Head of Investor Relations at

Affimed

June 2018 - May 2020

company logo

Head of Investor Relations at

Edge Therapeutics, Inc.

July 2016 - June 2018

company logo

Senior Vice President/Consultant at

Evc

July 2010 - June 2018

company logo

Senior Associate at

Wcg, A W2O Company

January 2008 - January 2009

company logo

Director at

LAZAR, a Finn Partners Company

November 2005 - November 2008

💼

Director, Investor Relations at

Genta

January 2004 - January 2005

company logo

Vice President, Analytical Services at

Thomson Reuters

September 2000 - December 2004

company logo

Director, Capital Markets Intelligence at

The Carson Group

June 1996 - September 2000

Logos provided by Logo.dev

Gregory Gin

Education

University of California, Santa Barbara

Frequently Asked Questions about Gregory Gin

What is Gregory Gin email address?

Gregory Gin's primary email address is ****@evcgroup.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Gregory Gin work for?

Gregory Gin is a Vice President, Investor Relations and Corporate Communications at Abeona Therapeutics, a company specializing in Commercial physical research.

Where Gregory Gin graduated from?

Gregory Gin holds a degree in from University of California, Santa Barbara.

How can I directly contact Gregory Gin?

To contact Gregory Gin directly, you can use the email address ****@evcgroup.com. Complete contact information is available upon registration with Muraena.

Who is Gregory Gin?

Gregory Gin is a seasoned professional with over 25 years of experience in investor relations and corporate communications, particularly within the life sciences sector. Currently serving as Vice President at Abeona Therapeutics, he has a proven track record of enhancing shareholder value and driving successful capital market strategies. His expertise spans across various therapeutic areas, including neurology and oncology, and he has led investor relations programs at multiple public companies. Gregory is recognized for his analytical skills and his ability to thrive in fast-paced environments. He has effectively managed communication strategies that have resulted in increased investor engagement and coverage. His strategic insights have supported substantial capital raises and investor targeting efforts, making him a valuable asset to any organization.

Gregory`s contact details

mail

****@evcgroup.com

****@abeonatherapeutics.com

Colleagues

avatar
Faith Charles Jd

Board Member

avatar
Madhav Vasanthavada

SVP, Chief Commercial Officer & Head of Business Development

Megan Callan

Executive Director, Head of Quality

avatar
Kate Imhoff

Vice President, Regulatory Affairs at Abeona Therapeutics

avatar
Joe Vazzano

Board Member and Audit Chair

avatar
Brendan O'malley

Senior Vice President, General Counsel

avatar
Carl Denny

Senior Vice President - Head of Regulatory Affairs

avatar
Brian Kevany

Senior Vice President, Chief Technical Officer and Chief Scientific Officer

avatar
Vishwas Seshadri

President & CEO

avatar
Alison Hardgrove

Chief People Officer

View Contact details (it's free)
Request Profile Removal